Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1983 1
1986 1
1987 2
1988 4
1989 3
1990 3
1991 6
1992 3
1993 5
1994 4
1995 7
1996 1
1997 2
1998 3
1999 1
2000 6
2001 5
2002 2
2003 4
2004 2
2005 8
2006 9
2007 11
2008 9
2009 11
2010 9
2011 13
2012 10
2013 12
2014 18
2015 16
2016 14
2017 14
2018 11
2019 14
2020 8
2021 12
2022 7
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

253 results

Results by year

Filters applied: . Clear all
Page 1
Obfuscating transparency?
Aschner M, Autrup H, Berry CL, Boobis AR, Cohen SM, Dekant W, Galli CL, Goodman JI, Gori GB, Greim HA, Kaminski NE, Klaassen CD, Klaunig JE, Lotti M, Marquardt HW, Moretto A, Pelkonen O, Sipes IG, Wallace KB, Yamazaki H. Aschner M, et al. Among authors: moretto a. Regul Toxicol Pharmacol. 2018 Aug;97:A1-A3. doi: 10.1016/j.yrtph.2018.07.004. Epub 2018 Jul 11. Regul Toxicol Pharmacol. 2018. PMID: 30017904
A new approach to the classification of carcinogenicity.
Doe JE, Boobis AR, Cohen SM, Dellarco VL, Fenner-Crisp PA, Moretto A, Pastoor TP, Schoeny RS, Seed JG, Wolf DC. Doe JE, et al. Among authors: moretto a. Arch Toxicol. 2022 Sep;96(9):2419-2428. doi: 10.1007/s00204-022-03324-z. Epub 2022 Jun 15. Arch Toxicol. 2022. PMID: 35701604 Free PMC article.
A framework for cumulative risk assessment in the 21st century.
Moretto A, Bachman A, Boobis A, Solomon KR, Pastoor TP, Wilks MF, Embry MR. Moretto A, et al. Crit Rev Toxicol. 2017 Feb;47(2):85-97. doi: 10.1080/10408444.2016.1211618. Epub 2016 Aug 11. Crit Rev Toxicol. 2017. PMID: 27685779 Free article. Review.
A 21st century roadmap for human health risk assessment.
Pastoor TP, Bachman AN, Bell DR, Cohen SM, Dellarco M, Dewhurst IC, Doe JE, Doerrer NG, Embry MR, Hines RN, Moretto A, Phillips RD, Rowlands JC, Tanir JY, Wolf DC, Boobis AR. Pastoor TP, et al. Among authors: moretto a. Crit Rev Toxicol. 2014 Aug;44 Suppl 3:1-5. doi: 10.3109/10408444.2014.931923. Crit Rev Toxicol. 2014. PMID: 25070413 Review.
Anesthesiological risks in mucopolysaccharidoses.
Moretto A, Bosatra MG, Marchesini L, Tesoro S. Moretto A, et al. Ital J Pediatr. 2018 Nov 16;44(Suppl 2):116. doi: 10.1186/s13052-018-0554-1. Ital J Pediatr. 2018. PMID: 30442160 Free PMC article. Review.
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma.
Sangro B, Chan SL, Kelley RK, Lau G, Kudo M, Sukeepaisarnjaroen W, Yarchoan M, De Toni EN, Furuse J, Kang YK, Galle PR, Rimassa L, Heurgué A, Tam VC, Van Dao T, Thungappa SC, Breder V, Ostapenko Y, Reig M, Makowsky M, Paskow MJ, Gupta C, Kurland JF, Negro A, Abou-Alfa GK; HIMALAYA investigators. Sangro B, et al. Ann Oncol. 2024 May;35(5):448-457. doi: 10.1016/j.annonc.2024.02.005. Epub 2024 Feb 19. Ann Oncol. 2024. PMID: 38382875 Free article. Clinical Trial.
253 results